GRIFOLS SA-ADR (GRFS) Fundamental Analysis & Valuation

NASDAQ:GRFS • US3984384087

Current stock price

7.525 USD
-0.09 (-1.25%)
Last:

This GRFS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GRFS Profitability Analysis

1.1 Basic Checks

  • In the past year GRFS was profitable.
  • GRFS had a positive operating cash flow in the past year.
  • In the past 5 years GRFS has always been profitable.
  • In multiple years GRFS reported negative operating cash flow during the last 5 years.
GRFS Yearly Net Income VS EBIT VS OCF VS FCFGRFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • GRFS has a Return On Assets of 2.04%. This is amongst the best in the industry. GRFS outperforms 88.25% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.63%, GRFS belongs to the top of the industry, outperforming 91.52% of the companies in the same industry.
  • The Return On Invested Capital of GRFS (4.57%) is better than 90.17% of its industry peers.
  • GRFS had an Average Return On Invested Capital over the past 3 years of 3.66%. This is significantly below the industry average of 18.95%.
  • The 3 year average ROIC (3.66%) for GRFS is below the current ROIC(4.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.04%
ROE 7.63%
ROIC 4.57%
ROA(3y)1.02%
ROA(5y)1%
ROE(3y)3.8%
ROE(5y)3.64%
ROIC(3y)3.66%
ROIC(5y)3.12%
GRFS Yearly ROA, ROE, ROICGRFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.34%, GRFS belongs to the top of the industry, outperforming 89.21% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GRFS has declined.
  • GRFS has a better Operating Margin (16.63%) than 92.87% of its industry peers.
  • GRFS's Operating Margin has declined in the last couple of years.
  • GRFS has a Gross Margin of 38.00%. This is in the better half of the industry: GRFS outperforms 73.03% of its industry peers.
  • In the last couple of years the Gross Margin of GRFS has declined.
Industry RankSector Rank
OM 16.63%
PM (TTM) 5.34%
GM 38%
OM growth 3Y12.82%
OM growth 5Y-1.86%
PM growth 3Y15.87%
PM growth 5Y-14.34%
GM growth 3Y1.07%
GM growth 5Y-2.09%
GRFS Yearly Profit, Operating, Gross MarginsGRFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. GRFS Health Analysis

2.1 Basic Checks

  • GRFS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, GRFS has about the same amount of shares outstanding.
  • GRFS has less shares outstanding than it did 5 years ago.
  • GRFS has a worse debt/assets ratio than last year.
GRFS Yearly Shares OutstandingGRFS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
GRFS Yearly Total Debt VS Total AssetsGRFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • GRFS has an Altman-Z score of 1.28. This is a bad value and indicates that GRFS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.28, GRFS is in the better half of the industry, outperforming 63.01% of the companies in the same industry.
  • GRFS has a debt to FCF ratio of 14.21. This is a negative value and a sign of low solvency as GRFS would need 14.21 years to pay back of all of its debts.
  • The Debt to FCF ratio of GRFS (14.21) is better than 89.40% of its industry peers.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that GRFS has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.61, GRFS is doing worse than 78.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 14.21
Altman-Z 1.28
ROIC/WACC0.81
WACC5.66%
GRFS Yearly LT Debt VS Equity VS FCFGRFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that GRFS has no problem at all paying its short term obligations.
  • GRFS's Current ratio of 2.51 is on the low side compared to the rest of the industry. GRFS is outperformed by 69.94% of its industry peers.
  • A Quick Ratio of 0.88 indicates that GRFS may have some problems paying its short term obligations.
  • GRFS has a worse Quick ratio (0.88) than 86.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 0.88
GRFS Yearly Current Assets VS Current LiabilitesGRFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

3

3. GRFS Growth Analysis

3.1 Past

  • GRFS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.76%.
  • Measured over the past 5 years, GRFS shows a small growth in Earnings Per Share. The EPS has been growing by 4.12% on average per year.
  • The Revenue has been growing slightly by 4.32% in the past year.
  • GRFS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.30% yearly.
EPS 1Y (TTM)4.76%
EPS 3Y8.55%
EPS 5Y4.12%
EPS Q2Q%41.77%
Revenue 1Y (TTM)4.32%
Revenue growth 3Y7.34%
Revenue growth 5Y6.3%
Sales Q2Q%94.71%

3.2 Future

  • The Earnings Per Share is expected to decrease by -7.18% on average over the next years.
  • GRFS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.97% yearly.
EPS Next Y-26.58%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
EPS Next 5Y-7.18%
Revenue Next Year-3.15%
Revenue Next 2Y5.3%
Revenue Next 3Y7.1%
Revenue Next 5Y6.97%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GRFS Yearly Revenue VS EstimatesGRFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
GRFS Yearly EPS VS EstimatesGRFS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

7

4. GRFS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.79, the valuation of GRFS can be described as very cheap.
  • Based on the Price/Earnings ratio, GRFS is valued cheaply inside the industry as 97.69% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, GRFS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 12.61, the valuation of GRFS can be described as correct.
  • Based on the Price/Forward Earnings ratio, GRFS is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, GRFS is valued a bit cheaper.
Industry RankSector Rank
PE 5.79
Fwd PE 12.61
GRFS Price Earnings VS Forward Price EarningsGRFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GRFS is valued cheaper than 97.30% of the companies in the same industry.
  • 98.46% of the companies in the same industry are more expensive than GRFS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.11
EV/EBITDA 7.33
GRFS Per share dataGRFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • GRFS has a very decent profitability rating, which may justify a higher PE ratio.
  • GRFS's earnings are expected to decrease with -24.68% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.41
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%

7

5. GRFS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.34%, GRFS is a good candidate for dividend investing.
  • GRFS's Dividend Yield is rather good when compared to the industry average which is at 1.30. GRFS pays more dividend than 99.23% of the companies in the same industry.
  • GRFS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 5.34%

5.2 History

  • The dividend of GRFS has a limited annual growth rate of 2.54%.
  • GRFS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.54%
Div Incr Years0
Div Non Decr Years0
GRFS Yearly Dividends per shareGRFS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 31.84% of the earnings are spent on dividend by GRFS. This is a low number and sustainable payout ratio.
DP31.84%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
GRFS Yearly Income VS Free CF VS DividendGRFS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
GRFS Dividend Payout.GRFS Dividend Payout, showing the Payout Ratio.GRFS Dividend Payout.PayoutRetained Earnings

GRFS Fundamentals: All Metrics, Ratios and Statistics

GRIFOLS SA-ADR

NASDAQ:GRFS (3/27/2026, 12:13:04 PM)

7.525

-0.09 (-1.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-27
Earnings (Next)05-11
Inst Owners33%
Inst Owner Change0.5%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap5.12B
Revenue(TTM)7.52B
Net Income(TTM)402.00M
Analysts77.14
Price Target12.99 (72.62%)
Short Float %2.51%
Short Ratio11.66
Dividend
Industry RankSector Rank
Dividend Yield 5.34%
Yearly Dividend0.22
Dividend Growth(5Y)2.54%
DP31.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.85%
PT rev (3m)-0.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.3%
EPS NY rev (3m)-1.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 5.79
Fwd PE 12.61
P/S 0.59
P/FCF 7.11
P/OCF 4.24
P/B 0.84
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)1.3
EY17.28%
EPS(NY)0.6
Fwd EY7.93%
FCF(TTM)1.06
FCFY14.06%
OCF(TTM)1.78
OCFY23.59%
SpS12.76
BVpS8.94
TBVpS-7.27
PEG (NY)N/A
PEG (5Y)1.41
Graham Number16.17
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 7.63%
ROCE 7.07%
ROIC 4.57%
ROICexc 4.8%
ROICexgc 11.12%
OM 16.63%
PM (TTM) 5.34%
GM 38%
FCFM 8.29%
ROA(3y)1.02%
ROA(5y)1%
ROE(3y)3.8%
ROE(5y)3.64%
ROIC(3y)3.66%
ROIC(5y)3.12%
ROICexc(3y)3.89%
ROICexc(5y)3.37%
ROICexgc(3y)8.95%
ROICexgc(5y)7.77%
ROCE(3y)5.67%
ROCE(5y)4.83%
ROICexgc growth 3Y30.14%
ROICexgc growth 5Y2.58%
ROICexc growth 3Y26.13%
ROICexc growth 5Y0.31%
OM growth 3Y12.82%
OM growth 5Y-1.86%
PM growth 3Y15.87%
PM growth 5Y-14.34%
GM growth 3Y1.07%
GM growth 5Y-2.09%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 14.21
Debt/EBITDA 4.98
Cap/Depr 94%
Cap/Sales 5.62%
Interest Coverage 2.35
Cash Conversion 61.55%
Profit Quality 155.22%
Current Ratio 2.51
Quick Ratio 0.88
Altman-Z 1.28
F-Score6
WACC5.66%
ROIC/WACC0.81
Cap/Depr(3y)67.96%
Cap/Depr(5y)76.71%
Cap/Sales(3y)2.47%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.76%
EPS 3Y8.55%
EPS 5Y4.12%
EPS Q2Q%41.77%
EPS Next Y-26.58%
EPS Next 2Y-32.23%
EPS Next 3Y-24.68%
EPS Next 5Y-7.18%
Revenue 1Y (TTM)4.32%
Revenue growth 3Y7.34%
Revenue growth 5Y6.3%
Sales Q2Q%94.71%
Revenue Next Year-3.15%
Revenue Next 2Y5.3%
Revenue Next 3Y7.1%
Revenue Next 5Y6.97%
EBIT growth 1Y8.29%
EBIT growth 3Y21.23%
EBIT growth 5Y5.1%
EBIT Next Year43.73%
EBIT Next 3Y20.32%
EBIT Next 5Y17.93%
FCF growth 1Y377.36%
FCF growth 3YN/A
FCF growth 5Y-3.55%
OCF growth 1Y734.85%
OCF growth 3YN/A
OCF growth 5Y-1.17%

GRIFOLS SA-ADR / GRFS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to GRFS.


What is the valuation status of GRIFOLS SA-ADR (GRFS) stock?

ChartMill assigns a valuation rating of 7 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.


What is the profitability of GRFS stock?

GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GRFS stock?

The Price/Earnings (PE) ratio for GRIFOLS SA-ADR (GRFS) is 5.79 and the Price/Book (PB) ratio is 0.84.


What is the financial health of GRIFOLS SA-ADR (GRFS) stock?

The financial health rating of GRIFOLS SA-ADR (GRFS) is 3 / 10.